Free Trial
NASDAQ:INVO

INVO Bioscience (INVO) Stock Price, News & Analysis

INVO Bioscience logo
$0.86 -0.01 (-1.31%)
As of 07/3/2025

About INVO Bioscience Stock (NASDAQ:INVO)

Key Stats

Today's Range
$0.84
$0.87
50-Day Range
$0.84
$2.33
52-Week Range
$0.63
$3.50
Volume
54,365 shs
Average Volume
1.59 million shs
Market Capitalization
$3.29 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive INVO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for INVO Bioscience and its competitors with MarketBeat's FREE daily newsletter.

INVO Stock News Headlines

I was wrong about Trump
I made a mistake. A mistake I feel very foolish about. After speaking with Donald Trump and some of his advisors, I believed him. I believed the promise that he would finally confront the single most dangerous threat to American life. That he would fix the ticking time bomb I’ve been warning about for 15 years. But I was wrong.
NAYA Biosciences Inc trading halted, news pending
NAYA Biosciences to effect 1-for-12 reverse split
See More Headlines

INVO Stock Analysis - Frequently Asked Questions

INVO Bioscience's stock was trading at $0.81 at the start of the year. Since then, INVO stock has increased by 6.7% and is now trading at $0.8640.

INVO Bioscience, Inc. (NASDAQ:INVO) released its earnings results on Monday, November, 15th. The company reported ($4.80) EPS for the quarter, missing analysts' consensus estimates of ($4.00) by $0.80. The company earned $0.22 million during the quarter, compared to analysts' expectations of $0.25 million.

INVO Bioscience shares reverse split before market open on Thursday, July 27th 2023.The 1-20 reverse split was announced on Thursday, July 27th 2023. The number of shares owned by shareholders was adjusted after the market closes on Thursday, July 27th 2023. An investor that had 100 shares of stock prior to the reverse split would have 5 shares after the split.

Shares of INVO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that INVO Bioscience investors own include NVIDIA (NVDA), NIO (NIO), Tesla (TSLA), Meta Platforms (META), Nikola (NKLA), Broadcom (AVGO) and Bilibili (BILI).

Company Calendar

Last Earnings
11/15/2021
Today
7/05/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Surgical & medical instruments
Sub-Industry
N/A
Current Symbol
NASDAQ:INVO
Fax
N/A
Employees
25
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$8.03 million
Net Margins
-122.79%
Pretax Margin
-122.32%

Debt

Sales & Book Value

Annual Sales
$5.77 million
Price / Cash Flow
N/A
Book Value
($2.06) per share
Price / Book
-0.42

Miscellaneous

Free Float
3,769,000
Market Cap
$3.29 million
Optionable
No Data
Beta
1.43
Options Trading Made Easy - Download Now Cover

Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.

Get This Free Report

This page (NASDAQ:INVO) was last updated on 7/5/2025 by MarketBeat.com Staff
From Our Partners